Supreme Court considers patents for ‘personal medicine’ tailored to individual patients

Posted on December 8th, 2011 by

With researchers looking more and more for ways to tailor drugs and tests to each patient’s needs, the Supreme Court on Wednesday considered how far companies can go to protect their profits in the burgeoning “personal medicine” field. The justices heard from lawyers from the Minnesota-based Mayo Clinic, which wants the court to throw out a patent held by Prometheus Laboratories, owned by Switzerland-based Nestle. Mayo argues the patent would keep its own medical test off the market, at the cost of better care for patients.

Washington Post (AP), 12/6/11

Additional coverage: Reuters, MinnPost, Bloomberg, Washington Post, Wall Street Journal, NY Times, Financial Express, KSWT Desert News (AZ), Kansas City Star, Capital.gr, Sacramento Bee

Tags: Legal / Leadership, Prometheus

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy